Blue Moon Life Sciences

Blue Moon Life Sciences is a Melbourne-based life sciences company founded by Dr. Angelo Perani and Shruti Rani. The company serves the Australian R&D and industry ecosystem by distributing life science raw materials – including mRNA and nucleotide products – and offering consultancy in biopharmaceutical development.

Dr. Perani brings deep scientific credentials: trained in France with a focus on programmed cell death, he went on to hold roles at Lonza UK, the Ludwig Institute for Cancer Research, and the Olivia Newton-John Cancer Research Institute, before leading scientific operations at biosimilar company NeuClone, where he helped advance two products to Phase I clinical trials under TGA oversight.

Shruti Rani brings the commercial backbone, with a strong background in finance, business development, and client relationship management across major multinational banks in India, including ICICI, HSBC, and HDFC.

Together, they position Blue Moon Life Sciences as a nimble, expertise-driven partner for companies navigating the growing biotech and mRNA space in Australia.